Immunoglobulin G expression and its colocalization with complement proteins in papillary thyroid cancer

Modern Pathology

Volumn 25, Issue 1, 2012, Pages 36-45

  Qiu, Yamei ^a   Korteweg, Christine ^a   Chen, Zhengshan ^a   Li, Jing ^a   Luo, Jin ^a   Huang, Guowei ^a   Gu, Jiang ^a,b,c  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c NONE   (China)

Author keywords

activation induced cytidine deaminase; C1q; immunoglobulin G; papillary thyroid cancer; RAG1; RAG2

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; COMPLEMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN RECEPTOR; MEMBRANE ANTIGEN; MESSENGER RNA; RAG1 PROTEIN; RAG2 PROTEIN; TUMOR ANTIGEN;

ADULT; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CANCER CELL; CANCER GROWTH; CELL TYPE; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LASER CAPTURE MICRODISSECTION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; THYROID PAPILLARY CARCINOMA;

EID: 84855358671     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.139     Document Type: Article

References (32)

1. Terry WD, Fahey JL. Subclasses of human gamma globulin based on differences in the heavy polypeptide chains. Science 1964;146:400-401.
2. Niu N, Zhang J, Guo Y, et al. Expression and distribution of immunoglobulin G and its receptors in the human nervous system. Int J Biochem Cell Biol 2011;43:556-563.
3. Zhang S, Mao Y, Huang J, et al. Immunoglobulin gene locus events in epithelial cells of lactating mouse mammary glands. Cell Mol Life Sci 2010;67:985-994.
4. Niu N, Zhang J, Sun Y, et al. Expression and distribution of immuglobulin G and its receptors in an immune privileged site: the eye. Cell Mol Life Sci 2011;68:2481-2492.
5. Zhao Y, Liu Y, Chen Z, et al. Immunoglobulin G (IgG) expression in human umbilical cord endothelial cells. J Histochem Cytochem 2011;59:474-488.
6. Qiu X, Zhu X, Zhang L, et al. Human epithelial cancers secrete immunoglobulin G with unidentified specificity to promote growth and survival of tumor cells. Cancer Res 2003;63:6488-6495. (Pubitemid 37255201)
7. Chen Z, Gu J. Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J 2007;21: 2931-2938. (Pubitemid 47372759)
8. Babbage G, Ottensmeier CH, Blaydes J, et al. Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res 2006;66: 3996-4000.
9. Chen Z, Huang X, Ye J, et al. Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades. Cancer 2010;116:1953-1963.
10. Lee G, Chu RA, Ting HH. Preclinical assessment of anti-cancer drugs by using RP215 monoclonal antibody. Cancer Biol Ther 2009;8:161-166.
11. Lucas SD, Kaelsson-Parra A, Nilsson B, et al. Tumorspecific deposition of immunoglobulin G and complement in papillary thyroid carcinoma. Hum Pathol 1996;27:1329-1335. (Pubitemid 26415328)
12. Hay ID, McConahey WM, Goellner JR. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc 2002;113:241-260.
13. Sculumberger MJ. Papillary and follicular thyroid carcinoma (review). N Engl J Med 1998;338:297-306.
14. Haymart MR. Understanding the relationship between age and thyroid cancer. Oncologist 2009;14: 216-221.
15. Kuriakose MA, Hicks Jr WL, Loree TR, et al. Risk group-based management of differentiated thyroid carcinoma. J R Coll Surg Edinb 2001;46:216-223.
16. Andersen PE, Kinsella J, Loree TR, et al. Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg 1995;170:467-470.
17. Jones MK. Management of papillary and follicular thyroid cancer. J R Soc Med 2002;95:325-326. (Pubitemid 34765404)
18. Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol 2009;9:729-740.
19. Witte DP, Welch TR, Beischel LS. Detection and cellular localization of human C4 gene expression in the renal tubular epithelial cells and other extrahepatic epithelial sources. Am J Pathol 1991;139: 717-724.
20. Andoh A, Fujiyama Y, Sakmoto H, et al. Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomas. Clin Exp Immunol 1998;111:477-483. (Pubitemid 28160888)
21. Yamakawa M, Yamada K, Tsuge T, et al. Protection of thyroid cancer cells by complement-regulatory factors. Cancer 1994;73:2808-2817. (Pubitemid 24166270)
22. Stover C. Dual role of complement in tumour growth and metastasis (review). Int J Mol Med 2010;25: 307-313.
23. Markiewski MM, Lambris JD. Is complement good or bad for cancer patients? A new perspective on an old dilemma. Trends Immunol 2009;30:286-292.
24. Raghavan M, Bjorkman PJ. Fc receptors and their interactions with immunoglobulins. Annu Rev Cell Dev Biol 1996;12:181-220. (Pubitemid 26422713)
25. Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 2007;7:715-725. (Pubitemid 47327396)
26. Finn RS, Press MF, Dering J, et al. Estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paclitaxel with lapatinib or placebo as first-line treatment in HER2-negative or unknown metastatic breast cancer. J Clin Oncol 2009; 27:3908-3915.
27. Li M, Feng DY, Ren W, et al. Expression of immunoglobulin kappa light chain constant region in abnormal human cervical epithelial cells. Int J Biochem Cell Biol 2004;36:2250-2257. (Pubitemid 39094446)
28. Pan Y, Yuhasz SC, Amzel LM. Anti-idiotypic antibodies: biological function and structural studies. FASEB J 1995;9:43-49.
29. Vieira JM, Santos SC, Espadinha C, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop. Eur J Endocrinol 2005; 153:701-709. (Pubitemid 41672417)
30. Mitsiades CS, Poulaki V, Fanourakis G, et al. Fas signaling in thyroid carcinoma is diverted from apoptosis to proliferation. Clin Cancer Res 2006; 12:3705-3712. (Pubitemid 44000250)
31. Laufer J, Oren R, Goldberg I, et al. Local complement genes expression in the mammary gland: effect of gestation and inflammation. Pediatr Res 1999;46: 608-612. (Pubitemid 29496492)
32. Tandon N, Morgan BP, Weetman AP. Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells. Immunology 1992;75:372-377.